This is a demo store. No orders will be fulfilled.
Life Sciences
Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas
The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.
Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.
The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.
We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.
We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.
-
12 Aug 2021  |  North America  |  Market Research
Frost Radar™: Non-Invasive Prenatal Testing, Global, 2021
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
Non-invasive prenatal testing (NIPT) provides an alternative to invasive, higher-risk tests such as amniocentesis, requiring a maternal blood sample to obtain cell-free DNA from both mother and fetus for analysis. Since NIPTs debut in 2011, laboratories and testing companies have made incremental upgrades to their non-invasive screens, improving ac...
$4,950.00 -
23 Jun 2021  |  Global  |  Market Research
Frost Radar™: Artificial Intelligence-enabled Drug Discovery in the Global Pharmaceutical Industry, 2021
A Benchmarking System to Spark Companies to Action—Innovation that Fuels New Deal Flow and Growth Pipelines
Pharmaceutical drug discovery and development suffers from declining success rates with new molecules, and the rate of return has shrunk from 16% in 2011 to almost 11% in 2018. Frost & Sullivan finds that traditional solutions focused primarily on data from limited sources and rule-based computational techniques used to address the understanding of...
$4,950.00 -
19 Dec 2013  |  Global  |  Market Research
Trends, Opportunities, and Challenges for the Latin American Diabetes Therapeutics Market
Innovative Drugs to Launch in the Next 3 Years, Impacting the Insulin and Non-insulin Markets
Biomarkers are no longer mere tools used to measure the criteria of a biological process characteristic. They are being increasingly used in patient stratification and customised medical interventions. This research service presents an overview and analysis of the global biomarker market. It provides revenue forecasts for biomarker on technological...
$2,450.00 -
12 Dec 2013  |  Latin America  |  Market Research
Analysis of the Brazilian Market for Reagent Kits in In Vitro Diagnosis
Healthcare Investments in the Public Sector Will Increase Market Growth
Despite Brazilian economic and industry challenges, the market for reagent kits in in vitro diagnosis (IVD) is experiencing robust growth. This research service leverages primary research that includes several companies manufacturing and marketing reagent kits in IVD, companies distributing or buying these products, and IVD experts, as well as seco...
$6,950.00 -
11 Dec 2013  |  Global  |  Market Research
Analysis of the US Retinal Therapeutics Market
Improvements in Administration and Efficacy Drive Growth
The global diabetes drug delivery market is mainly divided into injectable drug delivery and oral drug delivery systems. The trend will continue in 2015, as four major products: Afrezza (inhalable drug delivery product of MannKind distributed by Sanofi), Tanzeum (injectable pen), Xigduo XR (oral), and Xultophy (injectable pen) enter the US and Euro...
$4,950.00 -
03 Dec 2013  |  North America  |  Market Research
Analysis of the Global Tissue Diagnostics Market
Reimbursement Cuts and Hospital Consolidation Impede Uptake of Automated Equipment in Laboratories
This study investigates the global tissue diagnostics market for the period 2009 to 2017. The geographic regions are the US, Western Europe, APAC, and ROW through which the market is broadly classified by the advance stains segment and the pre-analytical segment. The study also includes a competitive analysis (SWOT), product analysis, revenue forec...
$10,000.00 -
22 Nov 2013  |  North America  |  Market Research
Vital Signs - Strategies beyond BRIC: An Update on the African In Vitro Diagnostics Market
This issue of Vital Signs, released on November 22, 2013, provides overview of global IVD market dynamics, discuss growth strategy, and explore early opportunities in the African IVD market. Additionally, a company spotlight is provided for Global BioDiagnostics based in Temple, Texas. The company is focused on developing affordable diagnostic tes...
$450.00 -
31 Oct 2013  |  North America  |  Market Research
Vital Signs - Healthcare News - The Analysts Perspective October 2013 Issue
This issue of Vital Signs, released on October 31, 2013, discusses perspectives of different Frost & Sullivan analysts on recent noteworthy news items for various markets including Pharma/Biotech, In Vitro Diagnostics, and Advanced Medical Technology.
$450.00 -
31 Oct 2013  |  Global  |  Market Research
Chinas 2013 Life Sciences Industry Outlook and Regulatory Review
Government Investments Could Make China the Third-largest Pharmaceutical Market in the World
China is predicted to become the third-largest pharmaceutical market in the world by the end of 2013 due to the governments considerable investment in the healthcare industry and the populations unmet healthcare needs. The life sciences industry is broad and involves a wide range of disciplines. This research service focuses on the trends and mar...
$4,950.00 -
24 Oct 2013  |  Asia Pacific  |  Market Research
Competitive Analysis of the Global Opioid Therapeutics Market
Opportunities Exist for Tamper-resistant Formulations
The research service presents an overview and analysis of the Asia-Pacific (APAC) contract research organisation (CRO) market and provides revenue forecasts by phase and therapeutic type. It discusses the major issues and challenges, unmet needs, and emerging trends in the market and covers the complete life cycle of the CRO industry, from pre-cli...
$4,950.00